NASDAQSNY

In: Finance

IvelinRadkov Sanofi (NASDAQ:SNY) and its partner Regeneron (NASDAQ:REGN) announced Wednesday that the EU drug regulator, the European Medicines Agency (EMA), has approved a label expansion for their asthma therapy Dupixent to include patients with the lung disorder, chronic obstructive pulmonary disease (COPD). The approval marks the first time a globalContinue Reading

In: Finance

Panama7/iStock Editorial via Getty Images Sanofi (NASDAQ:SNY) has sought initial bids for its $20B consumer healthcare spinoff as the French drugmaker moves forward with its divestment plans, which include a potential public listing, Bloomberg News reported Tuesday, citing people familiar with the matter. According to the people, the Paris-based pharmaContinue Reading